Beta-Galactosidase as a Transgenic Reporter for the Mapping and Phenotyping of MT and MT Melatonin Receptor-Expressing Cells.

Genetic technology allows inserting transgenic reporters such as beta-galactosidase (LacZ) into the loci of the Mtnr1a (MT) and Mtnr1b (MT) receptor genes to track MT and MT melatonin receptor expression. Given the limited sensitivity of nonradioactive in situ hybridization and the problematic specificity of existing melatonin receptor antibodies for immunohistochemistry, this new technology is a key tool to study the localization and the phenotypes of cells expressing melatonin receptors. Here we describe two protocols to detect transgenic LacZ expression driven by the MT or MT promoters either by the enzymatic activity of the transgenic LacZ enzyme or by using specific antibodies against LacZ with immunohistochemistry.

Nonradioactive In Situ Hybridization of MT1 Melatonin Receptor for the Identification of Melatonin Target Cells.

Identifying and phenotyping the target cells of a neuroendocrine messenger is one of the key steps to understand neuroendocrine networks and the physiological action of such messengers. In the absence of reliable antibodies directed against the receptor of a neuroendocrine messenger, detecting the expression of the messenger RNA of this receptor is an important tool to identify the target cells of a neuroendocrine messenger such as melatonin. While radioactive in situ hybridization has a higher sensitivity, nonradioactive in situ hybridization has a much better cellular resolution than radioactive in situ hybridization and is therefore better suited for phenotyping the target cells of melatonin.

Daily and Estral Regulation of RFRP-3 Neurons in the Female Mice.

Female reproductive success relies on proper integration of circadian- and ovarian- signals to the hypothalamic-pituitary-gonadal axis in order to synchronize the preovulatory LH surge at the end of the ovarian follicular stage with the onset of the main active period. In this study, we used a combination of neuroanatomical and electrophysiological approaches to assess whether the hypothalamic neurons expressing Arg-Phe amide-related peptide (RFRP-3), a gonadotropin inhibitory peptide, exhibit daily and estrous stage dependent variations in female mice. Furthermore, we investigated whether arginine vasopressin (AVP), a circadian peptide produced by the suprachiamatic nucleus regulates RFRP-3 neurons.

RFRP3 increases food intake in a sex-dependent manner in the seasonal hamster Phodopus sungorus.

In addition to its regulatory role in luteinising hormone secretion, Rfamide-related peptide 3 (RFRP3) has also been reported to modulate food intake in several mammalian species. Djungarian hamsters (Phodopus sungorus), similar to other seasonal mammals, display a remarkable inhibition of RFRP3 expression in winter short-day conditions, associated with decreased food intake and bodyweight. This species is therefore a valuable model for assessing whether RFRP3 might be involved in the seasonal control of feeding behaviour and investigating its possible brain targets.